First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis.
Sato W, Noto D, Araki M, Okamoto T, Lin Y, Yamaguchi H, Kadowaki-Saga R, Kimura A, Kimura Y, Sato N, Ishizuka T, Nakamura H, Miyake S, Yamamura T.
Sato W, et al. Among authors: sato n.
Ther Adv Neurol Disord. 2023 Mar 23;16:17562864231162153. doi: 10.1177/17562864231162153. eCollection 2023.
Ther Adv Neurol Disord. 2023.
PMID: 36993937
Free PMC article.